The Synthetic Biology market is expected to record a 20% CAGR over the forecast period. There are certain factors driving the market growth, including increased support from government and private organizations, increased R&D investment in new drug development, and reduced development and cost of DNA sequencing and synthesis. The increasing participation of government agencies, research […]
